Johnston N - Search Results

1

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease.

James SK, Oldgren J, Lindbäck J, Johnston N, Siegbahn A, Wallentin L. James SK, et al. Among authors: johnston n. Am Heart J. 2005 Apr;149(4):619-26. doi: 10.1016/j.ahj.2004.08.026. Am Heart J. 2005. PMID: 15990743

2

Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.

Venge P, Johnston N, Lagerqvist B, Wallentin L, Lindahl B; FRISC-II Study Group. Venge P, et al. Among authors: johnston n. Clin Chem. 2003 Jun;49(6 Pt 1):880-6. doi: 10.1373/49.6.880. Clin Chem. 2003. PMID: 12765983 Clinical Trial.

3

Biochemical indicators of cardiac and renal function in a healthy elderly population.

Johnston N, Jernberg T, Lindahl B, Lindbäck J, Stridsberg M, Larsson A, Venge P, Wallentin L. Johnston N, et al. Clin Biochem. 2004 Mar;37(3):210-6. doi: 10.1016/j.clinbiochem.2003.11.002. Clin Biochem. 2004. PMID: 14972643

4

Natriuretic peptides in unstable coronary artery disease.

Jernberg T, James S, Lindahl B, Johnston N, Stridsberg M, Venge P, Wallentin L. Jernberg T, et al. Among authors: johnston n. Eur Heart J. 2004 Sep;25(17):1486-93. doi: 10.1016/j.ehj.2004.06.017. Eur Heart J. 2004. PMID: 15342167 Review.

5

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.

Lindahl B, Lindbäck J, Jernberg T, Johnston N, Stridsberg M, Venge P, Wallentin L. Lindahl B, et al. Among authors: johnston n. J Am Coll Cardiol. 2005 Feb 15;45(4):533-41. doi: 10.1016/j.jacc.2004.10.057. J Am Coll Cardiol. 2005. PMID: 15708700 Free article. Clinical Trial.

6

Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes.

Mälarstig A, Tenno T, Johnston N, Lagerqvist B, Axelsson T, Syvänen AC, Wallentin L, Siegbahn A. Mälarstig A, et al. Among authors: johnston n. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2667-72. doi: 10.1161/01.ATV.0000191637.48129.9b. Epub 2005 Oct 20. Arterioscler Thromb Vasc Biol. 2005. PMID: 16239598

7

Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease.

Johnston N, Jernberg T, Lagerqvist B, Siegbahn A, Wallentin L. Johnston N, et al. Int J Cardiol. 2006 Nov 10;113(2):167-73. doi: 10.1016/j.ijcard.2005.11.006. Epub 2005 Dec 9. Int J Cardiol. 2006. PMID: 16338010 Clinical Trial.

8

Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.

Johnston N, Jernberg T, Lagerqvist B, Siegbahn A, Wallentin L. Johnston N, et al. Am J Cardiol. 2006 Mar 1;97(5):640-5. doi: 10.1016/j.amjcard.2005.09.123. Epub 2006 Jan 10. Am J Cardiol. 2006. PMID: 16490429

9

The antibody configurations of cardiac troponin I assays may determine their clinical performance.

James S, Flodin M, Johnston N, Lindahl B, Venge P. James S, et al. Among authors: johnston n. Clin Chem. 2006 May;52(5):832-7. doi: 10.1373/clinchem.2005.064857. Epub 2006 Mar 16. Clin Chem. 2006. PMID: 16543388

10

Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease.

Johnston N, Jernberg T, Lagerqvist B, Wallentin L. Johnston N, et al. Am Heart J. 2006 Dec;152(6):1052-8. doi: 10.1016/j.ahj.2006.07.014. Am Heart J. 2006. PMID: 17161052 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

557 results

Search Page